In the last decade, the number of new cases of
hepatitis has fallen dramatically in the United States, due largely to
the availability of vaccines against hepatitis A and B and strong
federally supported immunization programs, the Centers for Disease
Control and Prevention (CDC) reported Thursday.
Since 1995, new cases of reported acute hepatitis A have fallen by
88% to 1.5 cases per 100,000 people, the lowest level ever reported
since the government began collecting surveillance data more than 40
years ago.
Likewise, since 1990, new cases of hepatitis B have fallen 79% to
1.8 cases per 100,000 people, CDC researchers report surveillance
summary included in the March 16th issue of the Morbidity and Mortality
Weekly Report.
"The sharp declines in rates of hepatitis A and B are one of the big
public health success stories of the last 10 years," Dr. Kevin Fenton,
director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD
and TB Prevention, said in a statement.
"The drops in new cases of hepatitis A and hepatitis B," he added,
"are evidence that our prevention strategies have been successful,
particularly the widespread use of vaccines for hepatitis A and
hepatitis B. In order for these declines to continue, our prevention
efforts must be sustained."
Cases of hepatitis C have also declined steadily since the late
1980s, CDC reports, but cautions that surveillance for HCV is limited
because many individuals do not know they are infected with the virus.
The decline in HCV cases is likely due to reductions in high-risk
behaviors among injection drug users as well as increased efforts in
diagnosis.
Despite the declines, more than 100,000 new cases of viral hepatitis
were reported in 2005, the CDC notes. "Although the declines in acute
viral hepatitis are promising, the number of new infections remains
high particularly among unvaccinated adults," Dr. John Ward, director
of CDC's division of viral hepatitis said in a statement. "By
vaccinating infants against hepatitis B, we have made great progress in
reducing infections in children.
Last year, CDC issued new guidelines to increase vaccination
coverage among adults at risk for hepatitis B. "We need to encourage
vaccination of adults at high risk for hepatitis B, particularly those
with multiple sex partners or whose sex partners are already infected,
men who have sex with men, and injection drug users," Dr. Ward said.
"In addition to strengthening our efforts to prevent new cases of
viral hepatitis, we must also ensure that people with chronic hepatitis
are aware of their infection and know how to protect their health and
prevent transmission to others," Dr. Ward added.
MMWR 2007;56:1-24.
Copyright
© 2007 Reuters Limited. All rights reserved. Republication or
redistribution of Reuters content, including by framing or similar
means, is expressly prohibited without the prior written consent of
Reuters. Reuters shall not be liable for any errors or delays in the
content, or for any actions taken in reliance thereon. Reuters and the
Reuters sphere logo are registered trademarks and trademarks of the
Reuters group of companies around the world.
